TrialBone marrow transplantation2024

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.

Francis Ayuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.